A concise review of non-alcoholic fatty liver disease
NN Than, PN Newsome - Atherosclerosis, 2015 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic
syndrome and the incidence of which is rising rapidly due to the increasing epidemic of …
syndrome and the incidence of which is rising rapidly due to the increasing epidemic of …
Why is obesity such a problem in the 21st century? The intersection of palatable food, cues and reward pathways, stress, and cognition
Abstract Changes in food composition and availability have contributed to the dramatic
increase in obesity over the past 30–40 years in developed and, increasingly, in develo** …
increase in obesity over the past 30–40 years in developed and, increasingly, in develo** …
Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica
J Salas-Salvadó, MA Rubio, M Barbany, B Moreno… - Medicina clínica, 2007 - Elsevier
Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de
criterios de intervención terapéutica - ScienceDirect Skip to main contentSkip to article Elsevier …
criterios de intervención terapéutica - ScienceDirect Skip to main contentSkip to article Elsevier …
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial
Importance The effect of continued treatment with tirzepatide on maintaining initial weight
reduction is unknown. Objective To assess the effect of tirzepatide, with diet and physical …
reduction is unknown. Objective To assess the effect of tirzepatide, with diet and physical …
[HTML][HTML] Ожирение
ИИ Дедов, НГ Мокрышева, ГА Мельниченко… - Consilium …, 2021 - cyberleninka.ru
В декабре 2020 г. Научно-практическим советом Минздрава России были утверждены
клинические рекомендации «Ожирение», разработанные Российской ассоциацией …
клинические рекомендации «Ожирение», разработанные Российской ассоциацией …
Abdominal obesity and metabolic syndrome
Metabolic syndrome is associated with abdominal obesity, blood lipid disorders,
inflammation, insulin resistance or full-blown diabetes, and increased risk of develo** …
inflammation, insulin resistance or full-blown diabetes, and increased risk of develo** …
Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on …
Obesity is becoming a global epidemic in both children and adults. It is associated with
numerous comorbidities such as cardiovascular diseases (CVD), type 2 diabetes …
numerous comorbidities such as cardiovascular diseases (CVD), type 2 diabetes …
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a …
Background New obesity medications result in large weight losses. However, long-term
adherence in a real-world setting is challenging, and termination of obesity medication …
adherence in a real-world setting is challenging, and termination of obesity medication …
Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up
MJ Franz, JJ VanWormer, AL Crain, JL Boucher… - Journal of the American …, 2007 - Elsevier
OBJECTIVE: To assist health professionals who counsel patients with overweight and
obesity, a systematic review was undertaken to determine types of weight-loss interventions …
obesity, a systematic review was undertaken to determine types of weight-loss interventions …
Behavioral treatment of obesity
Weight loss treatment is recommended for adults with a body mass index (BMI) of 30 kg/m2
or higher, as well as those with BMI of 25 kg/m2 or higher who have weight-related …
or higher, as well as those with BMI of 25 kg/m2 or higher who have weight-related …